Absci (ABSI) Total Current Liabilities (2020 - 2026)
Absci (ABSI) reported Total Current Liabilities of $20.0 million for Q1 2026, down 26.58% on a YoY basis from $27.3 million in Q1 2025, and down 12.01% sequentially from $22.8 million in Q4 2025.
Absci (ABSI) Total Current Liabilities (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Total Current Liabilities data on file, last reported at $20.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 26.58% year-over-year to $20.0 million; the trailing twelve-month figure through Mar 2026 stood at $20.0 million (down 26.58% YoY), and the FY2025 full-year result was $22.8 million, down 20.56% from the prior year.
- Total Current Liabilities fell to $20.0 million in Q1 2026, from $22.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $41.9 million in Q1 2022 to a low of $20.0 million in Q1 2026.
- A 5-year average of $28.3 million and a median of $28.0 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 35.05% in 2023 and increased 22.99% in 2025, its largest moves.
- Tracing ABSI's Total Current Liabilities over 5 years: stood at $30.3 million in 2022, then declined by 2.35% to $29.6 million in 2023, then decreased by 3.05% to $28.7 million in 2024, then retreated by 20.56% to $22.8 million in 2025, then declined by 12.01% to $20.0 million in 2026.
- Business Quant data shows ABSI's Total Current Liabilities at $20.0 million in Q1 2026, $22.8 million in Q4 2025, and $29.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 20.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.03 Mn |
| Dec 31, 2025 | 22.77 Mn |
| Sep 30, 2025 | 29.71 Mn |
| Jun 30, 2025 | 31.32 Mn |
| Mar 31, 2025 | 27.28 Mn |
| Dec 31, 2024 | 28.66 Mn |
| Sep 30, 2024 | 26.69 Mn |
| Jun 30, 2024 | 25.47 Mn |
| Mar 31, 2024 | 25.29 Mn |
| Dec 31, 2023 | 29.56 Mn |
| Sep 30, 2023 | 27.97 Mn |
| Jun 30, 2023 | 25.48 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 30.27 Mn |
| Sep 30, 2022 | 30.03 Mn |
| Jun 30, 2022 | 31.69 Mn |
| Mar 31, 2022 | 41.88 Mn |
| Dec 31, 2021 | 33.86 Mn |
| Sep 30, 2021 | 30.25 Mn |
| Jun 30, 2021 | 29.76 Mn |